[Laser and chemotherapy and the immune status of patients with fibrous-cavernous tuberculosis].
Treatment outcomes were analysed for 245 patients with fibro-cavernous tuberculosis (FCT). 103 of them were exposed to adjuvant low-energy laser radiation. The addition of the radiation to combined treatment of FCT patients contributes to more efficient treatment. The benefit lies in less severe intoxication, infiltration, discontinuation of bacterial discharge, more intensive normalisation of T-cell immunity, arrest of active inflammation, diminished antigenemia, normalisation of specific immunological reactivity.
L V
LV
Sergeeva
V G
VG
Dobkin
A N
AN
Markov
D000293:Adolescent; D000328:Adult; D000917:Antibody Formation / Q000187:drug effects / Q000528:radiation effects; D000995:Antitubercular Agents / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects / Q000528:radiation effects; D007113:Immunity, Innate / Q000187:drug effects / Q000528:radiation effects; D053685:Laser Therapy; D008297:Male; D008875:Middle Aged; D014397:Tuberculosis, Pulmonary / Q000276:immunology / Q000628:therapy*
D000995:Antitubercular Agents